KYMR
Kymera Therapeutics Inc
111.80$
+1.2%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | +392.2% | -246.3% | – | – | – | – | |
| – | +302.4% | +113.7% | +36.0% | +24.2% | +19.8% | +106.8% | +12.7% | |
| – | +84.6% | +333.9% | +381.2% | +42.1% | +21.5% | +27.6% | +8.9% | |
| – | +50.2% | +332.8% | +252.3% | +42.0% | – | – | – | |
| – | +21.0% | +4,372.3% | -149.6% | – | – | -359.1% | – | |
| – | -60.8% | +1,609.8% | -82.4% | +77.6% | +1,115.8% | -62.8% | -88.7% | |
| – | +1,115.8% | +2,463.3% | -76.4% | – | +581.7% | -388.9% | +29.0% | |
| – | – | – | -97.1% | -46.4% | – | – | – | |
| – | +25.8% | +49.3% | +53.2% | +33.1% | -93.3% | +1,973.7% | -5.2% | |
| – | -34.0% | +728.6% | -13.5% | -38.9% | -97.3% | +14,424.1% | +62.7% | |
| – | +7.8% | -224.4% | – | -5.0% | +101.9% | -75.1% | +2,204.7% | |
| – | – | +354.9% | -265.2% | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.